0.00
Regulus Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
See More
Previous Close:
$8.16
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$564.26M
Revenue:
-
Net Income/Loss:
$-30.04M
P/E Ratio:
0.00
EPS:
-1.58
Net Cash Flow:
$-27.38M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Regulus Therapeutics Inc Stock (RGLS) Company Profile
Name
Regulus Therapeutics Inc
Sector
Industry
Phone
858-202-6300
Address
4224 CAMPUS POINT COURT, SAN DIEGO, CA
Compare RGLS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RGLS
Regulus Therapeutics Inc
|
0.00 | 564.26M | 0 | -30.04M | -27.38M | -1.58 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Regulus Therapeutics Inc Stock (RGLS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-27-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Aug-02-24 | Initiated | Oppenheimer | Outperform |
Mar-18-24 | Initiated | Leerink Partners | Outperform |
Mar-28-18 | Initiated | B. Riley FBR, Inc. | Neutral |
Jan-05-18 | Initiated | Leerink Partners | Outperform |
Jun-13-17 | Reiterated | Chardan Capital Markets | Buy |
Mar-06-17 | Reiterated | Wedbush | Outperform |
Jan-30-17 | Downgrade | Needham | Buy → Hold |
Jan-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
Dec-07-16 | Reiterated | Chardan Capital Markets | Buy |
Nov-02-16 | Reiterated | Needham | Buy |
Jul-25-16 | Reiterated | Chardan Capital Markets | Buy |
Jun-28-16 | Reiterated | Chardan Capital Markets | Buy |
Jun-28-16 | Reiterated | FBR Capital | Outperform |
Jun-28-16 | Reiterated | Needham | Buy |
Jun-07-16 | Reiterated | Chardan Capital Markets | Buy |
Apr-13-16 | Initiated | Chardan Capital Markets | Buy |
Dec-04-15 | Initiated | Wells Fargo | Outperform |
Jun-09-15 | Initiated | Guggenheim | Buy |
Apr-21-15 | Resumed | FBR Capital | Outperform |
Nov-24-14 | Initiated | Deutsche Bank | Buy |
Aug-07-14 | Reiterated | FBR Capital | Outperform |
Aug-14-13 | Reiterated | Needham | Buy |
View All
Regulus Therapeutics Inc Stock (RGLS) Latest News
Reversal Traders Monitor Regulus Therapeutics Inc. for EntryShort Term Buy Zone Stock Alerts Signal Entry - beatles.ru
What is the dividend policy of Regulus Therapeutics Inc. stockDynamic investment growth - jammulinksnews.com
What are the latest earnings results for Regulus Therapeutics Inc.Superior stock selection - jammulinksnews.com
What is Regulus Therapeutics Inc. company’s growth strategyAchieve breakthrough profits with smart strategies - jammulinksnews.com
How does Regulus Therapeutics Inc. compare to its industry peersOutstanding risk-reward balance - jammulinksnews.com
Does Regulus Therapeutics Inc. stock perform well during market downturnsConsistent wealth multiplication - jammulinksnews.com
How volatile is Regulus Therapeutics Inc. stock compared to the marketFree Consultation - jammulinksnews.com
When is Regulus Therapeutics Inc. stock expected to show significant growthUnlock daily market insights for better trades - jammulinksnews.com
What are analysts’ price targets for Regulus Therapeutics Inc. in the next 12 monthsGet professional advice for market timing - jammulinksnews.com
Is it the right time to buy Regulus Therapeutics Inc. stockUnlock powerful portfolio optimization tools - jammulinksnews.com
What analysts say about Regulus Therapeutics Inc. stockFree Market Volatility Navigation Tips - PrintWeekIndia
Is Regulus Therapeutics Inc. a good long term investmentTriple-digit growth rates - PrintWeekIndia
What drives Regulus Therapeutics Inc. stock priceHigh-yield trading alerts - Autocar Professional
Regulus Therapeutics Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
Regulus Therapeutics Inc Stock (RGLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):